Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | 6 | 0 | 2 | 0 | €59.18 | €110.00 | 85.874% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €114.50 | €109.00 | -4.803% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €100.90 | €109.00 | 8.028% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 10 | 0 | €63.34 | €100.27 | 58.296% |
| Evotec SE | 6 | 1 | 3 | 0 | €6.14 | €90.00 | 1366.993% |
| Gilead Sciences Inc | 11 | 0 | 1 | 0 | €77.06 | €85.74 | 11.260% |
| Intra-Cellular Therapies Inc. | 36 | 0 | 5 | 0 | €66.50 | €85.14 | 28.034% |
| Cytokinetics Inc. | 37 | 1 | 5 | 0 | €52.00 | €83.06 | 59.726% |
| Ultragenyx Pharmaceutical Inc. | 29 | 1 | 5 | 0 | €49.00 | €82.93 | 69.247% |
| Prothena Corp. plc | 15 | 0 | 2 | 0 | €15.40 | €77.94 | 406.073% |
| Insmed Inc. | 46 | 0 | 2 | 0 | €64.50 | €76.89 | 19.202% |
| Incyte Corp. | 14 | 2 | 2 | 0 | €61.50 | €76.76 | 24.816% |
| Exact Sciences | 20 | 0 | 4 | 0 | €62.28 | €75.89 | 21.855% |
| Dr. Reddy's Laboratories Ltd. ADR | 7 | 1 | 0 | 0 | €71.50 | €75.37 | 5.413% |
| Galmed Pharmaceuticals Ltd. | 13 | 0 | 0 | 0 | €6.40 | €68.81 | 975.078% |
| XOMA Corp. | 9 | 0 | 1 | 0 | €24.40 | €68.62 | 181.230% |
| MorphoSys AG | 6 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| Celldex Therapeutics | 23 | 0 | 6 | 0 | €28.00 | €62.17 | 122.033% |
| Halozyme Therapeutics Inc. | 25 | 0 | 4 | 0 | €53.94 | €58.58 | 8.598% |
| Bristol-Myers Squibb | 6 | 3 | 1 | 0 | €49.16 | €58.45 | 18.902% |
| Sanofi S.A. ADR | 12 | 0 | 5 | 0 | €51.00 | €55.25 | 8.341% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €55.19 | €55.00 | -0.344% |
| Agios Pharmaceuticals Inc. | 11 | 1 | 2 | 0 | €36.80 | €49.07 | 33.349% |
| Rhythm Pharmaceuticals | 17 | 0 | 2 | 0 | €44.73 | €48.11 | 7.560% |
| QIAGEN NV | 10 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |